KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 122 filers reported holding KEROS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $23,304,400 | +81.9% | 580,000 | +93.3% | 0.39% | +67.7% |
| Q1 2023 | $12,810,000 | -29.4% | 300,000 | -29.8% | 0.24% | -3.7% |
| Q2 2021 | $18,152,000 | -31.0% | 427,414 | 0.0% | 0.24% | -37.4% |
| Q1 2021 | $26,307,000 | +7.8% | 427,414 | +23.5% | 0.39% | +4.3% |
| Q4 2020 | $24,407,000 | – | 346,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 402,118 | $16,157,101 | 4.90% |
| Opaleye Management Inc. | 352,650 | $14,169,477 | 3.39% |
| Nantahala Capital Management | 497,161 | $19,975,929 | 1.93% |
| Parkman Healthcare Partners LLC | 276,815 | $11,122,427 | 1.93% |
| BRAIDWELL LP | 1,143,865 | $45,960,496 | 1.50% |
| First Light Asset Management, LLC | 416,830 | $16,748,229 | 1.31% |
| Yiheng Capital Management, L.P. | 554,151 | $22,265,787 | 1.20% |
| Orbimed Advisors | 1,514,734 | $60,862,012 | 1.10% |
| DAFNA Capital Management LLC | 47,661 | $1,915,019 | 0.52% |
| Eventide Asset Management | 580,000 | $23,304,400 | 0.39% |